Student candidates from the Fresno region celebrate at the conclusion of Blood Cancer United's 2026 Student Visionaries of the Year gala, where the seven-week campaign raised over $702,900 for blood cancer research and patient support. Blood Cancer United photo

A seven-week, student-led fundraising campaign in the Fresno region drew to a close on Saturday, March 14, raising over $700,000 for blood cancer research and patient support while supporting local high school students to develop future work-life skills.

Blood Cancer United — formerly The Leukemia & Lymphoma Society — revealed the results of its annual Student Visionaries of the Year program, a leadership initiative that challenges high school students to develop and execute fundraising campaigns while building skills in entrepreneurship, marketing and project management.

Top honors this year went to Team Sam, led by Coco Telesco and Lauren Kendall. Together the duo helped drive the regional fundraising total to $702,900. The campaign supports the nonprofit’s mission to cure blood cancers and improve quality of life for patients and their families.

Team Eagles, led by Tess Leslie, finished runner-up, while A2 For a Cure, led by Allison O’Neill and Aubry DeLeon, placed third.

 

“We are incredibly proud of these students and their commitment to making a difference,” said Blood Cancer United’s Fresno region Executive Director Alene Mestjian. “Their heroic work and compassion are driving real progress for patients and families affected by blood cancer.”

The Student Visionaries of the Year program builds on broader efforts by the organization to craft the next generations of community leaders while supporting ongoing research and advocacy efforts.

The nonprofit has invested over $2 billion in research worldwide and has contributed to advancements across blood cancer treatments. Founded in 1949, the organization focuses on research, patient support and advocacy, providing resources and pushing for more accessible and affordable cancer care.

The nonprofit provides free education and support services to patients and families and continues to support emerging therapies aimed at improving blood cancer treatment outcomes.